These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 27915246
1. Neutrophil-dependent pentraxin-3 and reactive oxygen species production modulate endothelial dysfunction in haemodialysis patients. dell'Oglio MP, Simone S, Ciccone M, Corciulo R, Gesualdo M, Zito A, Cortese F, Castellano G, Gigante M, Gesualdo L, Grandaliano G, Pertosa GB. Nephrol Dial Transplant; 2017 Sep 01; 32(9):1540-1549. PubMed ID: 27915246 [Abstract] [Full Text] [Related]
2. Plasma pentraxin 3 is a more potent predictor of endothelial dysfunction than high-sensitive C-reactive protein. Yasunaga T, Ikeda S, Koga S, Nakata T, Yoshida T, Masuda N, Kohno S, Maemura K. Int Heart J; 2014 Sep 01; 55(2):160-4. PubMed ID: 24632958 [Abstract] [Full Text] [Related]
3. Effect of renin angiotensin system blockade on pentraxin 3 levels in type-2 diabetic patients with proteinuria. Yilmaz MI, Axelsson J, Sonmez A, Carrero JJ, Saglam M, Eyileten T, Caglar K, Kirkpantur A, Celik T, Oguz Y, Vural A, Yenicesu M, Lindholm B, Stenvinkel P. Clin J Am Soc Nephrol; 2009 Mar 01; 4(3):535-41. PubMed ID: 19211665 [Abstract] [Full Text] [Related]
4. Cardio-protective effects of pentraxin 3 produced from bone marrow-derived cells against ischemia/reperfusion injury. Shimizu T, Suzuki S, Sato A, Nakamura Y, Ikeda K, Saitoh S, Misaka S, Shishido T, Kubota I, Takeishi Y. J Mol Cell Cardiol; 2015 Dec 01; 89(Pt B):306-13. PubMed ID: 26470821 [Abstract] [Full Text] [Related]
5. Source of Circulating Pentraxin 3 in Septic Shock Patients. Albert Vega C, Mommert M, Boccard M, Rimmelé T, Venet F, Pachot A, Leray V, Monneret G, Delwarde B, Brengel-Pesce K, Mallet F, Trouillet-Assant S. Front Immunol; 2018 Dec 01; 9():3048. PubMed ID: 30687307 [Abstract] [Full Text] [Related]
6. Plasma pentraxin-3 as a marker of bioincompatibility in hemodialysis patients. Oldani S, Finazzi S, Bottazzi B, Garlanda C, Baldassarre E, Valaperta S, Cuccovillo I, Albini M, Child M, Montanelli A, Graziani G, Badalamenti S. J Nephrol; 2012 Dec 01; 25(1):120-6. PubMed ID: 21725917 [Abstract] [Full Text] [Related]
7. Pentraxin 3 as a biomarker of local inflammatory response to vascular injury in systemic lupus erythematosus. Cieślik P, Hrycek A. Autoimmunity; 2015 Jun 01; 48(4):242-50. PubMed ID: 25401491 [Abstract] [Full Text] [Related]
8. Differential expression of pentraxin 3 in neutrophils. Razvina O, Jiang S, Matsubara K, Ohashi R, Hasegawa G, Aoyama T, Daigo K, Kodama T, Hamakubo T, Naito M. Exp Mol Pathol; 2015 Feb 01; 98(1):33-40. PubMed ID: 25449330 [Abstract] [Full Text] [Related]
9. Relationships between plasma pentraxin 3 levels and inflammation markers patients with tunneled permanent catheter in hemodialysis. Yigit IP, Dogukan A, Taskapan H, Comert M, Ilhan N, Ulu R, Aygen B. J Vasc Access; 2015 Feb 01; 16(5):377-81. PubMed ID: 26070095 [Abstract] [Full Text] [Related]
10. Inflammatory status in patients with chronic renal failure: the role of PTX3 and pro-inflammatory cytokines. Malaponte G, Libra M, Bevelacqua Y, Merito P, Fatuzzo P, Rapisarda F, Cristina M, Naselli G, Stivala F, Mazzarino MC, Castellino P. Int J Mol Med; 2007 Oct 01; 20(4):471-81. PubMed ID: 17786277 [Abstract] [Full Text] [Related]
11. Long pentraxin 3 (PTX3) expression and release by neutrophils in vitro and in ulcerative colitis. Savchenko AS, Inoue A, Ohashi R, Jiang S, Hasegawa G, Tanaka T, Hamakubo T, Kodama T, Aoyagi Y, Ushiki T, Naito M. Pathol Int; 2011 May 01; 61(5):290-7. PubMed ID: 21501295 [Abstract] [Full Text] [Related]
12. The proteomic profile of circulating pentraxin 3 (PTX3) complex in sepsis demonstrates the interaction with azurocidin 1 and other components of neutrophil extracellular traps. Daigo K, Yamaguchi N, Kawamura T, Matsubara K, Jiang S, Ohashi R, Sudou Y, Kodama T, Naito M, Inoue K, Hamakubo T. Mol Cell Proteomics; 2012 Jun 01; 11(6):M111.015073. PubMed ID: 22278372 [Abstract] [Full Text] [Related]
13. Long Pentraxin 3 as a Predictive Marker of Mortality in Severe Septic Patients Who Received Successful Early Goal-Directed Therapy. Kim SB, Lee KH, Lee JU, Ann HW, Ahn JY, Jeon YD, Kim JH, Ku NS, Han SH, Choi JY, Song YG, Kim JM. Yonsei Med J; 2017 Mar 01; 58(2):370-379. PubMed ID: 28120568 [Abstract] [Full Text] [Related]
14. Early and transient release of leukocyte pentraxin 3 during acute myocardial infarction. Maugeri N, Rovere-Querini P, Slavich M, Coppi G, Doni A, Bottazzi B, Garlanda C, Cianflone D, Maseri A, Mantovani A, Manfredi AA. J Immunol; 2011 Jul 15; 187(2):970-9. PubMed ID: 21677138 [Abstract] [Full Text] [Related]
15. Regulation of pentraxin-3 by antioxidants. Hill AL, Lowes DA, Webster NR, Sheth CC, Gow NA, Galley HF. Br J Anaesth; 2009 Dec 15; 103(6):833-9. PubMed ID: 19864306 [Abstract] [Full Text] [Related]
16. Plasma Pentraxin 3 Is Closely Associated with Peripheral Arterial Disease in Hemodialysis Patients and Predicts Clinical Outcome: A 6-Year Follow-Up. Zhou Y, Zhang J, Zhu M, Lu R, Wang Y, Ni Z. Blood Purif; 2015 Dec 15; 39(4):266-73. PubMed ID: 25924996 [Abstract] [Full Text] [Related]
17. Oxidative Stress-Induced Pentraxin 3 Expression Human Retinal Pigment Epithelial Cells is Involved in the Pathogenesis of Age-Related Macular Degeneration. Hwang N, Kwon MY, Woo JM, Chung SW. Int J Mol Sci; 2019 Nov 29; 20(23):. PubMed ID: 31795454 [Abstract] [Full Text] [Related]
18. The Effect of Corrected Inflammation, Oxidative Stress and Endothelial Dysfunction on Fmd Levels in Patients with Selected Chronic Diseases: A Quasi-Experimental Study. Yilmaz MI, Romano M, Basarali MK, Elzagallaai A, Karaman M, Demir Z, Demir MF, Akcay F, Seyrek M, Haksever N, Piskin D, Cimaz R, Rieder MJ, Demirkaya E. Sci Rep; 2020 Jun 02; 10(1):9018. PubMed ID: 32488098 [Abstract] [Full Text] [Related]
19. Long pentraxin PTX3 is upregulated systemically and centrally after experimental neurotrauma, but its depletion leaves unaltered sensorimotor deficits or histopathology. Oggioni M, Mercurio D, Minuta D, Fumagalli S, Popiolek-Barczyk K, Sironi M, Ciechanowska A, Ippati S, De Blasio D, Perego C, Mika J, Garlanda C, De Simoni MG. Sci Rep; 2021 May 05; 11(1):9616. PubMed ID: 33953334 [Abstract] [Full Text] [Related]
20. Pentraxin 3 as a marker of endothelial dysfunction in young women with polycystic ovary syndrome (PCOS). Wyskida K, Franik G, Pohl N, Markuszewski L, Owczarek A, Madej P, Chudek J, Olszanecka-Glinianowicz M. Scand J Clin Lab Invest; 2019 Oct 05; 79(6):419-423. PubMed ID: 31282210 [Abstract] [Full Text] [Related] Page: [Next] [New Search]